Literature DB >> 6197153

Treatment of bladder cancer with a combination of hyperthermia, radiation and bleomycin.

Y Kubota, T Shuin, T Miura, R Nishimura, S Fukushima, S Takai.   

Abstract

The treatment of urinary bladder cancer with hyperthermia in combination with radiation and bleomycin was investigated. Immediately following a daily course of external bladder irradiation (150-200 rad; total 4 week exposure of 3500-4000 rad), patients diagnosed with transitional cell carcinoma of the bladder were irrigated with a solution of warmed saline (intravesical temperature, 42 degrees C-43 degrees C), containing 30 micrograms/ml bleomycin. Of a total of 33 patients, complete responses were observed in 14 patients, and partial responses were observed in 10. The side effects of the combined treatment were limited to local symptoms of bladder and urethral irritation. These preliminary results suggest that the combined use of hyperthermia, radiation, and bleomycin may represent an effective conservative therapy for the management of bladder cancer in humans.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6197153     DOI: 10.1002/1097-0142(19840115)53:2<199::aid-cncr2820530202>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Radiofrequency capacitive hyperthermia combined with irradiation or chemotherapy for patients with invasive bladder cancers.

Authors:  T Uchibayashi; H Yamamoto; K Kunimi; K Koshida; K Nakajima
Journal:  Int Urol Nephrol       Date:  1995       Impact factor: 2.370

2.  Enhanced radioinduced cytotoxicity of cultured human bladder cancer cells using 43 degrees C hyperthermia or anticancer drugs.

Authors:  K Nakajima; H Hisazumi
Journal:  Urol Res       Date:  1987

3.  Use of methotrexate, vinblastine, adriamycin, and cisplatin in combination with radiation and hyperthermia as neo-adjuvant therapy for bladder cancer.

Authors:  S Noguchi; Y Kubota; T Miura; T Shuin; M Hosaka
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

4.  Intravesical bleomycin in bladder tumour prophylaxis.

Authors:  M Tripi; C Pavone; P Ammatuna; A Scotti; M Pavone-Macaluso
Journal:  Int Urol Nephrol       Date:  1986       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.